Eton Pharmaceutcials, Inc.

Eton Pharmaceuticals develops and commercializes pharmaceutical products, a business activity that inherently involves animal testing for regulatory compliance and product safety. The company’s pipeline and marketed products are subject to standard preclinical testing requirements that utilize animal models.

Cruelty Free Investors flags the company under its animal exploitation criteria, which captures commercial activities involving animals not covered by more specific child codes. As a pharmaceutical company, Eton’s operations are built on a foundation of animal-based research and testing to gain regulatory approval for its drug candidates. No specific incidents, fines, or alternative testing commitments were identified in the provided evidence to detail the scale or nature of this exploitation. The available regulatory filings focus on financial and commercial risks, not animal welfare practices.